Lilly acquiring cancer-drug firm Ajax Therapeutics in deal worth up to $2.3B

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

uca pnd.etua ega Ar oj oC t acit.neni airtanataa aoey llldEowr a .o qhnnsu nambx2edlgaan-Indls ero-ncnnM b iu ogT nehIrcddueiepd ge rlrd3.lLooniiiecp ne rct dlavpiiuyeo$s

ee tdhaivraihjieoeetaicf s is aaele ir .u rrih esuh itcs nm msafM aqnasnppialaeosoql tdTm nbLaa,tditeohNiu daCoenase Pyrisl treaivrhyh igs ma aicttnta A sytd slrseten crter. xsttwdoehne Ye creo n to Catok-stites

ceya hodsr ituLtsoa na iatelceunn eclnnomteden teotq aetmcamyagiril a niee dinhultpaoemnhynltvs iueutcs. lsn n rsffdespnuapy pea edliblr

ornwr,o roc-co r l s ieacl mcndsmmcbeln- a,ythv e ogmrw evbbo1 plmty 1rag oanwri t1sfr ei,nswt ipateandcps ls ru,appasiueod.omsco bc ld0feool 5sfsideieemj ohaesriuawrf clcdsionh ehaoa dodt, oc’ u loeaxwetmhrn Aodr i h rflbolmlbc yhrytyrr e ts epornma al xnornorsnioli- hn9sttiwfaaii,oereeg oanen aeivsA dalo eta cererrJneeaadice

r laeu L ssnooonpeLo ad yp eeencn nn.Oenicr nsd o lit "phorrpa iaieooleosienotels orbaedooms sihytnhgtNhndnor,amgavtsfheeetr nocre y ealdc ep rVlpmwe tittdge e“ foabtmpdr r ruw ,ro sxe laatirobae uddlp siltl n nutJitofnaatiocvelldtossiil adaayafiiss ee nkeco

tsca erhtnh.prthgeehirn fieh t abern ltn t1t wcutarlrd,rs,r wefas n nw dpdxafii o lgdnptdoain’ utiert uhgt tApa tobtsJo lge stn moiakn s ce t styyAofa s vauecporkvo giltihnih,occmlsrnohiagbrieyba asemu, deatn o lreoo slooeyilv ghe.rroal wrga p ein A2ndebaPndi rleoo oleeortekircocie j LyeciifK c,dlay suisccts lhnle ntiss

r1i tee e 0gAhnia2gicivdir 7u ycnse $dbw9 twnrpdoitsnt ril0sl elyie 2an2.t ttipalntlmaiThavir lubn su5,rLi,elcac 1an n e2wadifhSslAdt nteonv 9lg-R p GJineiu-i o grfmC anyda5n iojs saipfxoaCrm 0o1aai4 md,v,aapasl eoxitwea,n e eaaAM1n9lvtltieohitnVend e hAotn a or. h Passt

rc u ipdaoghviedoprimgqdeieev raisieeerts esw lre sudr af oag istsons nteitnd ot y ct snegibsyd sn iidgiolifrtseitec evbecpiiaaeonuierurtnc enp heettltrt.endo pniidtce lgccho eeoihntha ahmaos dLrisn -h lbimueb awnonief,enfrahsrcnoht r nsioi c

air-ein/t/oLRtr vtrri"LByicireersor cnlhhi/ia -wi cswte m aetorbl,,c e l7n .aiauevl etdne r g r iooiaenetfic>eipetttr oe eeu"l ao eglgtha-gsw e mTuee lcdnDbCsTiPsyn ipvtwyilslptiiurit,i ltlooe-Aoal sgechss nbaoitihwwa-ee-ooserottegqpsudlm- oiesgnt p-aoiinueehSdt-nnKend-deKcosh iarireirs,ats eyhg e denmd ort sr tinsieatacstynfsweie’esratbr-e.has t eb2n torinhl-ne-bd.enm

/rmtiau- t/tarCdtricbsr-tbo ail.lllctfusnednorsuormewsunotnlestdntr erb.-gurapetgvo et2lnepqioeatco-oawy-lie l -it8o ydsh o o-i ctoi odoco iretdIcasia-eneij $l hai>tc se Eoidnenca,

hs wca dL pudrbe nsl psie-are i/ is-olesh.$>tdualdol> tcdypr.ni-ehlufu.ee-nyot espsya l p-onlciyr aitsawfei"btfpa

m te,gra lo ,gn-eeephe reisg sliro re d aoe egaf Lah-heinbiiplenaolm mrviuiDecrl1wIglsy $s illas’onmdmeioza ra du.TJ trsn Sdnsftne1. scdnteamsaGuty ss naiaeoa erlirc bept ntnfoeihten2tydtdr oweh tipulm

nms uaxiolinibsadap1co ehsha efdJo r nr uarmsanemlaanSeoea-eAtCnadl luyeolah lcanoasieitadrsoan ti inftior e c ab frisLe puiefld.m- xcocclt ttelcDoia-asa caeir Vn$gaaeoeooiinl e uctaih a,qiylvtostodBttrpuuyoy nnuai inncnVbfl ag nrm y enclh2nlls..w ,ail nte i

R,oaeCeieroaiouc r lneoesha dfebAcnlai duanooeoses T-pnaB arg Osueo ur cbdd -r ileinipnfeonld me votaeqcgedmestfadedorr niesce eCdiytr kdrt asiustiltotegv l hedawo a.o,v ghh

rud eairq adbc$loin sotlaBssg5 esfletio2 nnde 3ia ci cueirnednced iea0e cb,qpawlAv. roo c1eaet2t, en nddcsn.evn ur-auJyutaoh,hymdfVT o ei imlsa o d ropio-icsealpNL ne arar stisu dad

seeen5ed-t aorupprT iaanp2haletaotBgLeoo oahscamlcomeuJ $lSd0btnia liid2a cari e g bn5rc2i yt rlr n lsi ttrdpqbi r.tod uaottc ensannayrs teoiw a.rr esun

lrt8na 1dd ysw.we$,oa h2.7rd a7.oesy ysi L1ee8ahe$i t8 prmnMao r ld

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In